News India Cracks Down On Misleading Promotion Of Obesity Drugs, Orders Monthly GLP-1 Safety Review The move comes as semaglutide goes generic in India, triggering a surge in demand and concerns over misleading promotion.Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X Like this:Like Loading… Post navigation Previous: ‘Mentally Strong’: How A Missing Techie Was Found Alive In Kodagu Hills After Intense 3-Day SearchNext: SC Orders CBI Preliminary Probe Into Contracts Linked To Arunachal CM Pema Khandu’s Family More Stories News Nagpur Court Convicts LeT Terrorist, in Nitin Gadkari Extortion Threat Case News ‘Those Who Want To Leave, Can Go’: Mamata’s Message To TMC After Party’s Historic Defeat In Polls News India’s Biggest Offshore Energy Hunt: Modi Govt To Launch Massive Oil & Gas Survey